Exploratory Analysis of Brigatinib Activity in Patients With Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer and Brain Metastases in Two Clinical Trials

Camidge, DR; Kim, DW; Tiseo, M; Langer, CJ; Ahn, MJ; Shaw, AT; Huber, RM; Hochmair, MJ; Lee, DH; Bazhenova, LA; Gold, KA; Ou, SHI; West, HL; Reichmann, W; Haney, J; Clackson, T; Kerstein, D; Gettinger, SN

Camidge, DR (reprint author), Univ Colorado, Ctr Canc, 1665 Aurora Ct, Aurora, CO 80045 USA.

JOURNAL OF CLINICAL ONCOLOGY, 2018; 36 (26): 2693

Abstract

PurposeIn patients with crizotinib-treated, anaplastic lymphoma kinase gene (ALK)-rearranged non-small-cell lung cancer (ALK-positive NSCLC), initial ......

Full Text Link